Skip to main content
Premium Trial:

Request an Annual Quote

Roche to Help Simulations Plus Develop Drug Interaction Software

NEW YORK (GenomeWeb News) – Simulations Plus said today that it has signed a multi-year collaboration pact with Hoffmann La Roche, under which the pharmaceutical firm will provide funding and feedback in developing the firm’s GastroPlus software program for drug-drug interaction studies.
Lancaster, Calif.-based Simulations Plus said Roche would provide funding for the equivalent of one full-time scientist for two years.
“This collaboration will accelerate the implementation of what we expect to be the most advanced drug-drug interaction capability in the industry,” Viera Lukacova, Simulation Plus’ product manager for GastroPlus, said in a statement. “We’re especially pleased to have Roche scientists involved in this effort, as they have provided invaluable feedback and guidance to the implementation of our PBPK (physiologically based pharmacokinetics) capability in GastroPlus.”

The firm did not disclose terms of the collaboration.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.